• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MetLife Announces First Quarter 2021 Preferred Stock Dividend Actions

    2/16/21 4:15:00 PM ET
    $PRE
    $MET
    $PRA
    Blank Checks
    Finance
    Life Insurance
    Finance
    Get the next $PRE alert in real time by email

    NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends:

    • Quarterly dividend of $9.47875000 per share on the company’s 5.250% fixed-to-floating rate non-cumulative preferred stock, Series C, with a liquidation preference of $1,000 per share.
    • Semi-annual dividend of $29.375 per share on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share.
    • Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE: MET PRE).
    • Quarterly dividend of $296.875 per share on the company’s 4.75% non-cumulative preferred stock, Series F, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.296875 per depositary share (NYSE: MET PRF).
    • Semi-annual dividend of $19.250 per share on the company’s 3.850% fixed rate reset non-cumulative preferred stock, Series G, with a liquidation preference of $1,000 per share.
    • Quarterly dividend of $0.25000000 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA), subject to the final confirmation that the company has met the financial tests specified in the certificate of designations for the Series A preferred stock, which the company anticipates will be made and announced on or about March 5,2021. The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock, and will set an ex-dividend date after the confirmatory announcement.

    The above dividends will be payable March 15, 2021, to shareholders of record as of Friday, February 26, 2021, due to the record date occurring on Sunday, February 28, 2021.

    About MetLife

    MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

    Forward-Looking Statements

    The forward-looking statements in this news release, such as “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it has no obligation to correct or update any of these statements.

    Get the next $PRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRE
    $MET
    $PRA

    CompanyDatePrice TargetRatingAnalyst
    Prenetics Global Limited
    $PRE
    2/11/2026$36.00Buy
    Roth Capital
    MetLife Inc.
    $MET
    1/6/2026$97.00Outperform → In-line
    Evercore ISI
    MetLife Inc.
    $MET
    12/16/2025$101.00Outperform
    Mizuho
    MetLife Inc.
    $MET
    9/19/2025$84.00Overweight → Neutral
    Piper Sandler
    MetLife Inc.
    $MET
    9/16/2025$95.00Outperform
    Wolfe Research
    ProAssurance Corporation
    $PRA
    4/10/2025Mkt Perform → Underperform
    Raymond James
    ProAssurance Corporation
    $PRA
    4/3/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    MetLife Inc.
    $MET
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    More analyst ratings

    $PRE
    $MET
    $PRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours

    Up to 733% Greater Potency Across 11 Key Nutrients, Including New Saffron Nootropic and Bioactive Vitamin Forms Two New Flavours — Mango + Passionfruit and Lemon + Orange Same Price for New and Existing Customers Full Supplement Facts Available at im8health.com/products/essentials NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced the launch of Daily Ultimate Essentials PRO, a new clinical-grade version of its flagship daily health supplement under the IM8 Health brand. Alongside the reformulated product, Pren

    2/23/26 9:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference

    MetLife, Inc. (NYSE:MET) today announced that Ramy Tadros, regional president of MetLife's U.S. Business and head of MetLife Holdings, will participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on Wednesday, March 4, 2026, beginning at 10:25 a.m. (ET). A live webcast of the presentation will be available over the internet at https://event.summitcast.com/view/VSr8zRPFYu9jT7Rm69ptdC/fnXahDQq5cAwNB3QpWHPxq. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation will be available until Wednesday, March 11, 2026, at 11:59 p.m. (ET) a

    2/18/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

    Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic Transformation Completed with Divestitures and Focus on IM8 Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero DebtCompany to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at https://ir.prenetics.com NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium he

    2/18/26 9:11:26 AM ET
    $PRE
    Blank Checks
    Finance

    $PRE
    $MET
    $PRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Executive Vice-President Lisenby Jeffrey Patton

    4 - PROASSURANCE CORP (0001127703) (Issuer)

    1/8/26 11:30:09 AM ET
    $PRA
    Property-Casualty Insurers
    Finance

    SEC Form 4 filed by President & CEO Rand Edward Lewis Jr

    4 - PROASSURANCE CORP (0001127703) (Issuer)

    1/8/26 11:28:22 AM ET
    $PRA
    Property-Casualty Insurers
    Finance

    SEC Form 4 filed by Chief Financial Officer Hendricks Dana S

    4 - PROASSURANCE CORP (0001127703) (Issuer)

    1/8/26 11:25:15 AM ET
    $PRA
    Property-Casualty Insurers
    Finance

    $PRE
    $MET
    $PRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on Prenetics Group Ltd. with a new price target

    Roth Capital initiated coverage of Prenetics Group Ltd. with a rating of Buy and set a new price target of $36.00

    2/11/26 7:52:37 AM ET
    $PRE
    Blank Checks
    Finance

    MetLife downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded MetLife from Outperform to In-line and set a new price target of $97.00

    1/6/26 8:46:59 AM ET
    $MET
    Life Insurance
    Finance

    Mizuho initiated coverage on MetLife with a new price target

    Mizuho initiated coverage of MetLife with a rating of Outperform and set a new price target of $101.00

    12/16/25 8:59:16 AM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    SEC Filings

    View All

    SEC Form 10-K filed by MetLife Inc.

    10-K - METLIFE INC (0001099219) (Filer)

    2/19/26 4:34:30 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 6-K filed by Prenetics Global Limited

    6-K - Prenetics Global Ltd (0001876431) (Filer)

    2/18/26 9:28:49 AM ET
    $PRE
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by ProAssurance Corporation

    SCHEDULE 13G/A - PROASSURANCE CORP (0001127703) (Subject)

    2/17/26 5:06:07 PM ET
    $PRA
    Property-Casualty Insurers
    Finance

    $PRE
    $MET
    $PRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ProAssurance Corporation

    SC 13G/A - PROASSURANCE CORP (0001127703) (Subject)

    11/14/24 1:28:29 PM ET
    $PRA
    Property-Casualty Insurers
    Finance

    Amendment: SEC Form SC 13G/A filed by Prenetics Global Limited

    SC 13G/A - Prenetics Global Ltd (0001876431) (Subject)

    11/14/24 12:30:15 PM ET
    $PRE
    Blank Checks
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    $PRE
    $MET
    $PRA
    Financials

    Live finance-specific insights

    View All

    Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

    Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic Transformation Completed with Divestitures and Focus on IM8 Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero DebtCompany to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at https://ir.prenetics.com NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium he

    2/18/26 9:11:26 AM ET
    $PRE
    Blank Checks
    Finance

    MetLife Announces First Quarter 2026 Preferred Stock Dividend Actions

    Declares Series D, E and F Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of wh

    2/17/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call

    NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced it will release financial results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Wednesday, February 18, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts. Date:Wednesday, February 18, 2026Time:10:00 a.m. Eastern TimeDial-in:1-877-425-9470International Dial-in:1-201-389-0878

    2/11/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    $PRE
    $MET
    $PRA
    Leadership Updates

    Live Leadership Updates

    View All

    Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

    Ollie Bearman becomes the latest elite athlete to invest in NASDAQ:PRE, underscoring a deep belief in the brand's mission and products.IM8, co-founded by David Beckham, continues to attract top-tier athletes who prioritize scientifically validated and trusted nutritional support.IM8 has become one of the fastest-growing supplement brands globally, achieving an extraordinary US$100 million in Annual Recurring Revenue in just 11 months from launch.Bearman's rapid rise – including a historic points-scoring Ferrari debut at just 18—cements his reputation as one of motorsport's brightest young talents. NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE), a leading

    2/13/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    MetLife Investment Management Completes Acquisition of PineBridge Investments

    The combination brings together global scale and deep specialization, accelerating MetLife's growth in asset management MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), closed today on its acquisition of PineBridge Investments (PineBridge). The combined business manages $734.7 billion1 of assets, serving clients around the world. Accelerating growth in asset management is a top priority for MetLife in its New Frontier strategy. The acquisition brings together MIM's institutional strength and scale with PineBridge's global footprint and deep specialization to position MIM as a top-tier diversified global asset manager. "Toget

    12/30/25 5:15:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife and Global Citizen Announce Major Partnership to Drive Economic Change and Foster Resilient Communities

    MetLife Foundation Commits $9 Million to FIFA Global Citizen Education Fund Today at the 2025 Global Citizen Festival, MetLife, a leading financial services company providing insurance and employee benefits, proudly announced becoming a major partner with Global Citizen, the world's largest movement to end extreme poverty, with a new three-year partnership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250926660696/en/NEW YORK, NEW YORK - SEPTEMBER 27: (L-R) Michael Roberts and Nuria Garcia speak onstage during the 2025 Global Citizen Festival at Central Park on September 27, 2025 in New York City. (Photo by Noam Galai/Getty

    9/27/25 9:15:00 PM ET
    $MET
    Life Insurance
    Finance